Wall Street Journal

Originally posted in the Wall Street Journal by Jonathan D. Rockoff  Under increasing pressure to expand access to experimental medicines, Johnson & Johnson has arranged for an independent panel to review requests from seriously ill patients who want to try an unapproved drug even if they aren’t participating in the drug’s testing. The committee of […]